Electronic medical record firm Practice Fusion Inc. promoted former PayPal Inc. executive Jason Portnoy to be the company’s CFO.
Portnoy was the CFO of Palo Alto-based information analytics firm Palantir Technologies Inc. before joining Practice Fusion in November as vice president of finance.
At PayPal he was VP of financial planning through its IPO and acquisition by eBay Inc. (NSDQ:EBAY) in 2002 and also served as Clarium Capital Management LLC’s CFO, according to Practice Fusion. Clarium founder Peter Thiel’s investment portfolio includes Palantir Technologies and Facebook.
"Both Practice Fusion and our users stand to gain from Jason’s leadership. He has intimate knowledge of start-up operations as well as experience driving growth and expansion for some of the world’s most sophisticated technology companies," Practice Fusion CEO Ryan Howard said in prepared remarks.
The company’s cloud-based EMR system is advertising-supported and offered to medical practices for free. Its network has 70,000 users serving 8 million patients and is the fastest growing in the country, according to the company.
Here’s the latest personnel changes from medical device, diagnostics and life science companies around the nation. For more recent hirings and firings, check out MassDevice’s compilation of the latest personnel moves.
- Uptake Medical announces Scott Huennekens elected to board
Uptake Medical Corp. announced that Volcano Corp. (NSDQ:VOLC) CEO Scott Huennekens joined the company’s board. Huennekens has served as president, CEO and director at Volcano since April 2002. He led the company from a pre-revenue start-up to its IPO in 2006 and its current market-leading position through consistent growth by utilizing innovative technologies, strong clinical science and focused expansion throughout the global markets. From 2000-2002, he headed Digirad Corporation, a medical device imaging company. From 1993-1997 he was at Baxter Healthcare’s Cardiovascular Group (Edwards Lifesciences). Huennekens is a member of the Board of Directors of Medical Device Manufacturers Association and BIOCOM. He received his B.S. in Business Administration from USC and an M.B.A. from Harvard.
- Genstar Capital bumps two up to VP
Genstar Capital LLC, a middle market private equity firm that focuses on investments in selected segments of the life sciences, healthcare, financial services, software, and industrial technology industries promoted Roman Margolin and Eli Weiss to VP. Both were previously senior associates. Prior to joining Genstar, Margolin was an associate with Willis Stein & Partners, where he focused on investments in education, media, and healthcare sectors. Previously, he was an Analyst in the investment banking group of J.P. Morgan in Chicago. Margolin serves on the boards of Genstar portfolio companies Granite Global Solutions, Netsmart Technologies and PRA International. Prior to joining Genstar, Weiss was an associate at Hellman & Friedman LLC. Previously, he worked for Greenhill & Co. in New York as an Analyst in the Mergers & Acquisitions, Restructuring and Principal Investing groups.
- Tibion taps new board
Tibion Corp., the privately held Silicon Valley firm developing a bionic leg for stroke rehabilitation, announced the successful closure of a $10.2 million financing round, a new board of directors and a new board chairman. Tibion announced appointment of board member Randy Lindholm as chairman. Lindholm is a widely recognized advisor to and on the boards of numerous medical device companies. Lindholm has served as chairman, president and CEO of VidaMed Inc., which was sold to Medtronic Inc. (NYSE:MDT). Joining CEO Charles Remsberg and Lindholm on the board will be Conrad Wang, principal at Three Arch Partners, and Daniel Omstead, CEO at Hambrecht & Quist Capital Management, as well as current investor John Steuart, managing partner at Claremont Creek Ventures.